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Drug utilization studies may be one of the major design of optimizing the cost-
effectiveness of treatment regimens and drugs that used to compare the costs and effects
of alternative therapies. Human albumin (HA) is widely used for hypoalbuminemia and
other diseases from deficiency of blood and liver factors. HA cost in the clinical setting is
still controversial And Since use of albumin an established second line therapy process
which is to be used in supportive drug for patients .on this study Trying to find first
albumin protocol therapy cost was evaluated Then appropriate practice to be Alternate.
A prospective, cross-sectional research was performed in “Shaheed Rajaei” Cardiovascular,
Medical and Research Center during a 6-month continuous interval, in which, 300 patients
have been evaluated  .The study included patients who on a daily basis take albumin
from the central pharmacy of  Shaheed  Rajaei hospital  attaints time of receipt drug until
discharge from hospital or termination of treatment were studied continuously.
Demographic data including dose, intervals and durations have been registered, and
then compared with international guidelines such as Data analyses have been done by
SPSS 16 software. The results of this study indicated that among 300 in-patients who
had prescribed albumin prescription assumed inappropriate for 281 patients (93.7%),
The most common reason was incorrect indication of prescription without checking
serum albumin level (56.39%) .base on this study the most reasons of albumin use were
ascites and edema (57.9%),during the course of CABG(27.5%),hypoalbuminemia and
hypoproteinemia(33.3%),acute nephritis(17.6%),hemodialysis(19.6%). also rate of
infusion error was (16.5 %)and error related to dosages of order was ( 23.8 %).according
to guidelines dosage of adminstration must be base on weight and serum albumin level
that not be considred in intensive wards. According to data from this study suggests that
You can see the protocol therapy based on the patient’s needs  Albumin consumption to
reduce the cost of treatment and  The lack of effectiveness of the drug, especially compared
to other alternative medicines reduced.
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Drug utilization studies may be one of
the major design of optimizing the cost-
effectiveness of treatment regimens and drugs that
used to compare the costs and effects of alternative
therapies . Serum therapy, patients in the ICU and
CCU , one of the main challenges in the health
system. Drug utilization evaluation studies Present
valid reports, on the costs and effectiveness   of
drugs. Albumin is a regulator of circulating blood
And it is create  80 and 70 percent  of plasma oncotic
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pressure1. The proper  Indications of albumin
involves the use of a variety of shocks
(hemorrhagic and hemorrhagic bread), liver
problems, burns, cerebral ischemia, cardiac
surgery, neonatal hyperbilirubinemia, nephrotic
syndrome, organ transplantation2. But in compare
with guidelines  many cases the use of albumin in
the hospital is not correct3. Albumin as a major
serum used in intensive care units in hospitals are
not consumed properly, it is not a first-line
treatment. The high volume consumer has always
been associated with error and are prospective
studies need to control and monitor the drug usage.
Dur (Drug Utilization Review) is One way of
assessing the quality and quantity of medication
used4. DUE programs or qualitative DUR studies
during multilateral actions Information of rational
drug use, collect, organize, analyze and report.
albumin Due to its use in critically ill patients, high
prices and ineffective in patients with indication
for administration of albumin in them can not be
seen, is a good choice for DUR studies. DUR
studies in addition to controlling health care costs,
is also the basis for drug development. However,in
prospective studies that study was done in this
way, You can quickly get to the complications and
problems related to drug administration and
immediately corrected5,6. This study is designed
to evaluate the pattern of albumin and its use in
patients in intensive care in hospital .
MATERIAL AND METHOD
This prospective study was performed at
special wards of Shahid Rajaie Hospital, Tehran,
Iran. adults older than 18 years in five different
units including one ICU and  four CCUs were
included in this research.The program was
conducted from March to August 2015.patiants
with  immediate emergency surgery,End-stage
kidney disease (estimated GFR<20 mL/min - based
on serum/ plasma creatinine), Medical history of
MI within the past six months,Patients who have
Cirrhosis and Signs or symptoms of acute MI on
admission (Serum troponin level d”0.1 u g/L) and
Patients who have side effects of albumin were
excluded from this study.we designed  DUE forms
that involved number of ordered and prescribed
albumin vials, dosage and frequency of
administration, indications based on guidelines
and demographic information about the patients
such as serum creatinine,smoking, history of
underlying diseases such as heart or kidney  or
liver disease. some parameter such as ClCr ,total
pro level,serum albumin and range of hepatic
factors calculated. Appropriate or inappropriate
albumin  prescriptions were evaluated according
to factors such as dosage or duration of prescribing
albumin ,indication and total cost per patiant . then
we  analyses clinical data were by using SPSS
statistical analysis software 16.
RESULT
Patients’ demographics
During the study period, a total of 300
patients with a mean age of 56.35±14.7 years
received albumin during a six months  study . ,
73.3% Of these patiants were male and 26.7% were
female .The results of this study indicated that
among 300 in-patients who had prescribed albumin
prescription assumed inappropriate for 281 patients
(93.7%), The most common reason was incorrect
indication of prescription without checking serum
albumin level (56.39%) .base on this study the most
reasons of albumin use were ascites and edema
(57.9%),during the course of
CABG(27.5%),hypoalbuminemia and
h y p o p r o t e i n e m i a ( 3 3 . 3 % ) , a c u t e
nephritis(17.6%),hemodialysis(19.6%). also  rate of
infusion error was (16.5 %) and error related to
dosages of order was ( 23.8 %).according to
guidelines dosage of adminstration must be base
on weight and serum albumin level that not be
considred in intensive wards.(table 1) show the
proper indications of albumin adminstration.
Demographic characterization of patients
include general information , medical history
,duration of therapy and serum creatinine, has been
presented in Table 2. The total number of  used
vials was 6950  and the patients received a mean
number of 23.12  vials ranging from 1 to 68 vials.
Our findings showed that albumin treatment course
in our patients were 16.78 days.
Since the participating hospital was a
tertiary center for cardiovascular diseases, the
distribution of albumin prescriptions were mostly
encountered in Intensive Care Unit (ICU) and
Cardiovascular Care Unit (CCU). Our analysis
showed that patients receiving albumin were
1471FARSAD et al., Biosci., Biotech. Res. Asia,  Vol. 13(3), 1469-1477 (2016)
admitted to the care units 61.2% in ICU and 38.8%
in CCU.and
Table 1 also summarizes the mean plasma
levels of AST (aspartate aminotransferase), ALT
(alanine aminotransferase), alkaline phosphatase,
albumin, total protein, hematocrit and creatinine of
the study participants. Of these variables,
although serum albumin is the most important index
that may help in decision making for albumin use,
only for 140 patients (46.66%) this value was
measured. More interestingly, in our study,
albumin levels showed a mean value of 4.1±1.2 g/
dL (range 2.2- 4.5 g/dL) which is well above the
accepted cutoff for any prescription (2.0 g/dL).
According to a study Albumin does not
have any advantage over other alternative
solutions
And it has more advers effect in patiants
with underlying diseases and Albumin is more
expensive than other alternative medicines patiants
with immediate emergency surgery,End-stage
kidney disease (estimated GFR<20 mL/min - based
on serum/ plasma creatinine),Medical history of
MI 1within the past six months,Patients who have
Cirrhosis and Signs or symptoms of acute MI on
admission (Serum troponin level d”0.1 u g/L) and
Patients who have side effects of albumin were
excluded from this study  because albumin can
had more advers effect in these patiants.
This table present the average number
and percent of albumin used in Different ward
,based on this study the most incorrect use of
albumin in  ICU and the most cause of error in this
part relaited to Non-performing lab tests properly
and Lack of attention to the guidelines of
appropriate indications of albumin adminstration.
Albumin is an expensive drug and
Improper use of this drug Imposes large costs to
patients and hospitals,according to this study
2,596,125 dollars estimated as extra total cost
because of improper use of vials,also per patiant
cost was 8653.75 dollars .
DISCUSSION
Albumin as a major serum used in
intensive care units in hospitals are not consumed
properly, it is not a first-line treatment. If the non-
protein crystalloid solutions and colloid can not
be used or if the desired effect was seen after
consumption albumin can be used . Incorrect
administration  of  albumin are as noted
belowHypoalbuminemia, using albumin as a source
of nutrition, acute and chronic pancreatitis, support
the patient’s blood pressure during dialysis ,
Ovarian hyperstimulation syndrome , Hepatorenal
syndrome and increase the likelihood of drug
efficacy (figure 2). These cases have been
diagnosed inappropriate on the basis of the
Consensus Exercise7,8 . The high volume consumer
has always been associated with  error and are
prospective studies need to control and monitor
the drug usage.
The role of   albumin infusion in critically
ill patients in the hospital during more than 20 years
because of the high price of these products and
their side effects and limited supply have been
discussed. Many studies have evaluated the
correct use of albumin in hospitals and academic
centers that shows The use of albumin in many
cases has not been properly, In some of these
studies, after reforming consumption patterns and
the use of appropriate guidelines The consumption
of these products and costs are reduced. . In an
observational study in 10 academic medical center
in America proper use of albumin and used non-
protein colloidal solutions were measured in 969
cases That only 24% good and 62% of the
consumption of these products have been
misplaced9,10,11.
In two meta-analysis study that was
conducted in 1998, it was shown that the
consumption of non-protein albumin or colloids
can lead to increased mortality in chronically ill
patients . The first meta-analysis of 37 reviews
about the RTC was that in 26 of these studies,
colloids were compared with crystalloid. The results
showed that fluid replacement in patients using
colloidal solutions can increase 4%the absolute
risk of mortality.
In the second meta-analysis of RCT 30 in
the administration of albumin, or plasma protein
derivatives with or without crystalloid solutions
were compared, it was found that administration
of albumin and 6% increased risk of death.
In a study conducted in Italy Martelli
Antonietta and his colleagues, the impact of the
Directions for Use of albumin in 2 hospital with
third hospital without the use of albumin were
taking appropriate guidelines, looked. The results
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Table 2. Patients’demographics and underlying
diseases of the study participants
Variable (N=300) Results*
Age, years 56.39±14.07
Weight 69.83±8.62
Sex 26.7 % ; female
73.3 % : male
Mortality rate 41.66 % : Discharge
58.33% : death
Length of stay(day) 16.78±14.25
Admission ward
Intensive care unit 189 (61.2)
Cardiovascular care unit 111 (39.8)
Underlying disease
Admission during the course of CABG 30 (27.5)
Acute Nephritis
19.89(17.6)
hypoalbuminemia and 24.76(33.3)
hyponatremia
Hemodialysis 28(19.6)
ascites and edema 27(57.9)
Number of used albumin vials 23.12±38.9 (1-68)
Concurrent use of furosemide 69 (58.5)
Lab values
Serum albumin 4.1±1.2 (2.2-4.5)
Total protein 7.9±2.9 (3.7-8.3)
Serum creatinine 1.8±0.7 (0.6-4.1)
Hematocrit 42.5±6.1 (22.0-53.0)
AST 89.8±157.2 (10-785)
ALT 62.1±148.1 (7-791)
ALP 299.6±173.6 (85-568)
CABG: Coronary Artery Bypass Graft;
ALT: Alanine transaminase
AST: Aspartate transaminase
 ALP: Alkaline phosphatase
*Mean ± SD (range) for continues variables;
 Frequency (%) for nominal variables.
of this study showed that during 2000 and 2001 at
two hospitals that used the proper procedure,
Albumin decreased, while consumption in the third
hospital albumin increased over the years has
shown. Finally, this study showed that the use of
appropriate guidelines on the use of albumin can
reduce the inappropriate use of these products
and reduce costs 12,13,14.
In another study conducted in Belgium
Somers A et al., Using albumin was studied in a
University Hospital, Albumin in the hospital as an
alternative to albumin (at very low levels of serum
albumin), an increase of intravascular volume and
maintain patient hemodynamically was used to
improve tissue perfusion. In 1994, an agreement
was made public in Belgium on the use of albumin
and albumin Indications in which other alternatives
were confirmed , After the preparation and
communication of instructions and do DUE in the
hospital for 4 months during the consumption of
albumin in the hospital among The use of albumin
in 90 patients (21%) of 115 cases were observed
deviation from the instructions. Within 5 years of
follow-up of this study showed that using the
instructions on the amount of albumin
consumption fell 50.1% from 1994 to 1999. . Finally
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Table 3. Shows  frequency  of  underlying disease in
five special wards of shahid rajai hospital
dieseases Frequency %
Heart failure(n=87) 29
Diabetic(n=7) 2.3
Pulmunary edema(n=37) 12.3
Renal failure(n=38) 12.7
intestine Obstruction(n=8) 2.7
Pulmunary edema +TB1(n=14) 4.7
Encephalopathy(n=9) 3
Endocarditis +TVR2(n=8) 2.7
DVT3(N=9) 3
DHF4+ Diabetic(n=9) 3
DVT+PE(n=4) 1.3
RF5+DHF+ Encephalopathy(n=8) 2.7
AV6 modification(n=10) 3.3
MS7(n=8) 2.7
DHF+HTN +COPD (n=4) 1.3
PE+ RF(n=8) 2.7
Others (n=32) 10.7
total 300
1 TB: Tuberculosis
2 TVR: Tricuspid Valve Repair
3 DVT: deep vein thrombosis
4 DHF: diastolic heart failure
5 RF: renal failure
6 AV: Atrioventricular
7 MS : Multiple sclerosis
Fig. 1. Shows the frequency of underlying diseases
came to the conclusion that the acceptance and
use of guidelines on the use of albumin can reduce
its consumption and costs15
In a study of albumin DUE consumption
in Brazil was evaluated at a hospital. In 99 patients
and 33.1% of 1475 vials of used  albumin was proper
and albumin improper used was  61.8% and 4.6%
of Disagreements and 0.4% were reported in
unknown cause17,18
An other study in Iran in 1999 and has
been in the hospital Burn which shows The use of
albumin in 97% of cases for improper and
inconsistent with protocols ASHP (Directions for
Use of albumin, non-protein crystalloid solutions
and colloidal solutions, respectively).
The results of a study on the use of
albumin DUE Acute care hospitals in New York
found that 87%of 770 vials of albumin 25% of the
54 patients, had been prescribed
inconveniently19,20.
In a recent study it was done  in Shariati
Hospital In 1281 vials for 135 patients, only 411
bottles in 34prescription are suitable bases and is
used on guidline based21.
Our study also showed that In most
patients , no Measurement of blood albumin levels
prior to the administration of albumin are not done
properly. The amount of  2.0 g / dL is  a well
accepted Criterion to define the cut off22,23.
The results of this study indicated that
among 300 in-patients who had prescribed albumin
prescription assumed inappropriate for 281 patients
(93.7%), The most common reason was incorrect
indication of prescription without checking serum
albumin level (56.39%) .base on this study the most
reasons of albumin use were ascites and edema
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Table 4 . The rate of  inappropriate albumin usage
per patiants   in the special wards of shahid rajai
hospital
Department Percent of pationt Personal average
recive albumin in use  of albuminin
last 6 mounths last 6 mounths
ICU A 15.41 % 22.69
CCUC 10 % 15.46
PCCUA 5.12 % 9.036
CCUB 8.45 % 11.95
CCUF 9.02 % 13.69
Total rajaiee 10.54 % 23.1
hospital
Table 5. Cost Estimation by Improper use of the Albumin
Albumin February- April - May- June- July- July Costs Costs
vials march march April May June (dollar) (rial)
Post A 146 194 91 43 78 80 237000 853,200,000
ICU-A 200 420 400 360 552 390 870750 3,134,700,000
CCU-B 240 135 198 220 178 148 419625 1,510,650,000
CCU-C 100 116 235 105 109 299 361500 1,301,400,000
CCU-F 255 370 200 380 430 251 707250 2,546,100,000
total 941 1235 1124 1108 1374 1168 2,596,125 9,346,050,000
Albumin is an expensive drug and Improper use of this drug Imposes large costs to patients and
hospitals,according to this study 2,596,125 dollars estimated as extra total cost because of improper use
of vials,also per patiant cost was 8653.75 dollars .
Fig. 2. frequency and number of The vials used for different indications in shahid rajaeei hospital.the most most
improper indication was in edema and ascites(n=28,54.90%)
(57.9%),during the course of
CABG(27.5%),hypoalbuminemia and
h y p o p r o t e i n e m i a ( 3 3 . 3 % ) , a c u t e
nephritis(17.6%),hemodialysis(19.6%). also rate of
infusion(16.5 %)and  the dosages of order was
incorrect( 23.8 %).according to guidelines dosage
of adminstration must be base on weight and serum
albumin level that not be considred in intensive
wards.so all these errors Imposes a large cost to
the hospital In the event that albumin has the same
efficacy as other alternatives.
CONCLUSION
According to data from this study
suggests that You can see the protocol therapy
based on the patient’s needs  Albumin
consumption to reduce the cost of treatment and
The lack of effectiveness of the drug, especially
compared to other alternative medicines reduced.
Drug Utilization Evaluation (DUE) is an effective
Study Approach to identify inappropriate
prescribing and to improve rational use of albumin
and other expensive drugs.Reforming
consumption patterns in most parts of the world is
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Compare the use of albumin in Rajaee hospital with Albert Einstein Hospital
doing and Has helped to reduce the side effects
and costs resulting from the indiscriminate use of
medicines.For example  in this below figure compare
the use of albumin after with before doinng project.
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